Prostate cancer risk assessment in men with an initial PSA below 3 ng/mL: results from the Goteborg randomized population-based prostate cancer screening trial

摘要

Objective: To evaluate the long-term outcome of men with an initial prostate-specific antigen (PSA) level below 3 ng/mL and whether the free-to-total (F/T PSA) ratio is a useful prognostic marker in this range.